Clinical Trial Update: Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on long-term safety and tolerability of cariprazine as an adjunctive treatment for major depressive disorder; results completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-08-21